@isciencewriter

International Science Writer (ISW) creating and sharing up-to-the-minute news about #lifescience, #biotech and #pharma industries.

 Hitchin, UK
internationalsciencewriter.com
Joined January 2012
  • Tweets18.6K
  • Following3.4K
  • Followers5.1K
1.9KMedia
NEW OPTURA®PALM® Handheld Contactless Biomass Sensor from Aber Offers Accurate Cell Density Measurement in Seconds Without Sampling. Technology is used across biopharmaceutical, brewing, biofuel industries etc biotechnewswire.ai/202408082…
78
IScienceWriter retweeted
ProductLife Group@PLG_EU20 Apr 2023
Check out Asif R. 's DSI - DS InPharmatics, a PLG company Business Development Director's insightful interview with CPHI Online on supply chain issues, data analytics, and their impact on the regulatory landscape in the life sciences industry. Read more: lnkd.in/dG4k3VBq
Supply chain issues and data analytics

ALT Supply chain issues and data analytics

1
1
172
Stem Cells May Move to the Front Line against Multiple Sclerosis genengnews.com/topics/transl… via @DrSuePearson for @GENbio #stemcells #biotech #biopharma

Stem Cells May Move to the Front Line against Multiple Sclerosis

Researchers maintain that patients with severe multiple sclerosis should be able to receive autologous hematopoietic stem cell transplantation as a first-line therapy.

genengnews.com
1
89
IScienceWriter retweeted
Dr. Simon
@goddek23 Jan 2023
𝗦𝘂𝗿𝗽𝗿𝗶𝘀𝗲, 𝘀𝘂𝗿𝗽𝗿𝗶𝘀𝗲! "Vitamin D deficiency was found in 82.2% of COVID-19 cases and 47.2% of population-based controls (p<0.0001)." (bit.ly/3Wr4srL) And frankly speaking, I doubt that anybody would get ill at all with 25(OH)D levels above 50 ng/mL.
537
4,182
319
12,045
1,173,012
Last chance to register for this #webinar on how to scale-up your #cellculture the easy way. #biotech
Sartorius@SartoriusGlobal21 Jun 2022
If one-parameter bioreactor scaling approaches are hurting your efficiency and productivity, you’ll be glad to know there is a better solution. Join this webinar to learn more: srtrs.info/r/6vd17 #cellculture #bioreactor #biotech
Diabetes risk rises after COVID, massive study finds nature.com/articles/d41586-0… #covid19 #vaccines #diabetes

Diabetes risk rises after COVID, massive study finds

Nature - Even mild SARS-CoV-2 infections can amplify a person’s chance of developing diabetes, especially for those already susceptible to the disease.

nature.com
20 months after the 40,000 trial subjects were given the Oxford/AZ vaccine, no loss of protection from serious illness has been observed in under 70s who had 2 doses of AstraZeneca almost 2 years ago - Sarah Gilbert. AZ designed as a 2 dose vaccine, not 3, not boost-dependent.
15
60
7
124
Special thanks to my top new tweeps this week @Neon_Jesse, @athlonelabs
A huge congratulations to Steve Rees for receiving @ELRIG_UK’s Inaugural Lifetime Achievement Award today at #DrugDiscovery2021, in recognition of his significant contribution to the #lifescience sector.
5
7
Gallenkamp Launches Smart New Website and Brochure b3cnewswire.com/202109302271…
Are you finding scaling-up and scaling-down between #bioreactors a challenge? Then click the link to register for this free .@SartoriusGlobal #webinar on September 14th view6.workcast.net/register?… #vaccines xitter.cf/isciencewriter/status/…
1
Are you finding scaling-up and scaling-down between #bioreactors a challenge? Then click the link to register for this free .@SartoriusGlobal #webinar on September 14th view6.workcast.net/register?… #bioprocessing xitter.cf/isciencewriter/status/…
Since no matter how many people refuse to listen: Facts Matter. #Covid_19
22
150
4
577
Are you finding scaling-up and scaling-down between #bioreactors a challenge? Then click the link to register for this free .@SartoriusGlobal #webinar on September 14th view6.workcast.net/register?… #biopharma xitter.cf/isciencewriter/status/…
1
1
Are you finding scaling-up and scaling-down between #bioreactors a challenge? Then click the link to register for this free .@SartoriusGlobal #webinar on September 14th view6.workcast.net/register?… #pharma xitter.cf/isciencewriter/status/…
Are you finding scaling-up and scaling-down between #bioreactors a challenge? Then click the link to register for this free .@SartoriusGlobal #webinar on September 14th view6.workcast.net/register?… #bioreactor xitter.cf/isciencewriter/status/…
Are you finding scaling-up and scaling-down between #bioreactors a challenge? Then click the link to register for this free .@SartoriusGlobal #webinar on September 14th view6.workcast.net/register?… #biotech xitter.cf/isciencewriter/status/…
Are you finding scaling-up and scaling-down between #bioreactors a challenge? Then click the link to register for this free .@SartoriusGlobal #webinar on September 14th view6.workcast.net/register?… #biotech xitter.cf/isciencewriter/status/…
IScienceWriter retweeted
Sartorius@SartoriusGlobal27 Aug 2021
Are you finding scaling-up and scaling-down between bioreactors a challenge? Then register for our scaling webinar on September 14 to gain insights from our experts into simplifying and de-risking the process. ow.ly/BhO450FYAd1
1
IScienceWriter retweeted
Sartorius@SartoriusGlobal8 Jun 2021
Our vaccine experts reflect on the lessons learned following the industry’s yearlong response to the COVID-19 pandemic. Watch the video to hear Amélie Boulais and Piergiuseppe Nestola answer important questions about current and future vaccine development. ow.ly/iTYD50EoqRw
1
2
4
Load more